Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP909988.RAEj-n5dY7kYbag1DE31Q2vpTPGiBt7Q2VlBocj95vhlY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP909988.RAEj-n5dY7kYbag1DE31Q2vpTPGiBt7Q2VlBocj95vhlY130_assertion type Assertion NP909988.RAEj-n5dY7kYbag1DE31Q2vpTPGiBt7Q2VlBocj95vhlY130_head.
- NP909988.RAEj-n5dY7kYbag1DE31Q2vpTPGiBt7Q2VlBocj95vhlY130_assertion description "[Among BRCA1-associated patients, the RR was worse (objective response [OR], 23% vs 38%; progressive disease [PD], 60% vs 19%; P < 0.001); and the median PFS shorter (2.2 vs 4.9 months; P = 0.04) compared with sporadic patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP909988.RAEj-n5dY7kYbag1DE31Q2vpTPGiBt7Q2VlBocj95vhlY130_provenance.
- NP909988.RAEj-n5dY7kYbag1DE31Q2vpTPGiBt7Q2VlBocj95vhlY130_assertion evidence source_evidence_literature NP909988.RAEj-n5dY7kYbag1DE31Q2vpTPGiBt7Q2VlBocj95vhlY130_provenance.
- NP909988.RAEj-n5dY7kYbag1DE31Q2vpTPGiBt7Q2VlBocj95vhlY130_assertion SIO_000772 21761396 NP909988.RAEj-n5dY7kYbag1DE31Q2vpTPGiBt7Q2VlBocj95vhlY130_provenance.
- NP909988.RAEj-n5dY7kYbag1DE31Q2vpTPGiBt7Q2VlBocj95vhlY130_assertion wasDerivedFrom befree-2016 NP909988.RAEj-n5dY7kYbag1DE31Q2vpTPGiBt7Q2VlBocj95vhlY130_provenance.
- NP909988.RAEj-n5dY7kYbag1DE31Q2vpTPGiBt7Q2VlBocj95vhlY130_assertion wasGeneratedBy ECO_0000203 NP909988.RAEj-n5dY7kYbag1DE31Q2vpTPGiBt7Q2VlBocj95vhlY130_provenance.